Luis Masana
0000-0002-0789-4954
Hospital Universitari Sant Joan de Reus
20 papers found
Refreshing results…
Lipidomics of triglyceride‐rich lipoproteins derived from hyperlipidemic patients on inflammation
Association between Nordic and Mediterranean diets with lipoprotein phenotype assessed by 1HNMR in children with familial hypercholesterolemia
Glycoprotein Serum Concentrations Assessed By 1H-NMR are Increased in Patients With High Blood Pressure
PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk
Unveiling the Role of the Fatty Acid Binding Protein 4 in the Metabolic-Associated Fatty Liver Disease
Glycoprotein Profile Measured by a 1H-Nuclear Magnetic Resonance Based on Approach in Patients with Diabetes: A New Robust Method to Assess Inflammation
MCF-7 Drug Resistant Cell Lines Switch Their Lipid Metabolism to Triple Negative Breast Cancer Signature
Combination lipid-lowering therapy as first-line strategy in very high-risk patients
Altered Serum Metabolic Profile Assessed by Advanced 1H-NMR in Breast Cancer Patients
Serum glycoproteins A and B assessed by 1H-NMR in familial hypercholesterolemia
Hepatic Lipidomics and Molecular Imaging in a Murine Non-Alcoholic Fatty Liver Disease Model: Insights into Molecular Mechanisms
Glycoprotein Profile Assessed by 1H-NMR as a Global Inflammation Marker in Patients with HIV Infection. A Prospective Study
Derivation and validation of SIDIAP-FHP score: A new risk model predicting cardiovascular disease in familial hypercholesterolemia phenotype
Autosomal dominant hypercholesterolemia in Catalonia: correspondence between clinical-biochemical and genetic diagnostics in 967 patients studied in a multicenter clinical setting
Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society
Lipoprotein profile assessed by 2D-1H-NMR and subclinical atherosclerosis in children with familial hypercholesterolaemia
Plasma inducible degrader of the LDLR, soluble low-density lipoprotein receptor, and proprotein convertase subtilisin/kexin type 9 levels as potential biomarkers of familial hypercholesterolemia in children
Caveolin 3 deficiency myopathy associated with dyslipidemia: Treatment challenges and possible pathophysiological association
How many familial hypercholesterolemia patients are eligible for PCSK9 inhibition?
Impact of epidermal fatty acid binding protein on 2D-NMR–assessed atherogenic dyslipidemia and related disorders
Missing publications? Search for publications with a matching author name.